Atlas Trials

Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation

Clinical trial NCT02474927 · COMPLETED

Trial details

NCT number
NCT02474927
Sponsor
John F. McDyer, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Transplant Rejection
Start date
2015-11-01
Primary completion
2020-11-09
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.